Prevalence and correlates of myocardial scar in a US cohort

Evrim B. Turkbey, Marcelo S. Nacif, Mengye Guo, Robyn L. McClelland, Patricia B R P Teixeira, Diane E. Bild, R. Graham Barr, Steven Shea, Wendy S Post, Gregory Burke, Matthew J. Budoff, Aaron R. Folsom, Chia Ying Liu, Joao Lima, David A. Bluemke

Research output: Contribution to journalArticle

Abstract

IMPORTANCE Myocardial scarring leads to cardiac dysfunction and poor prognosis. The prevalence of and factors associated with unrecognizedmyocardial infarction and scar have not been previously defined using contemporarymethods in a multiethnic US population. OBJECTIVE To determine prevalence of and factors associated withmyocardial scar in middle- and older-aged individuals in the United States. DESIGN, SETTING, AND PARTICIPANTS The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease (CVD) at baseline in 2000-2002. In the 10th year examination (2010-2012), 1840 participants underwent cardiac magnetic resonance (CMR) imaging with gadolinium to detectmyocardial scar. Cardiovascular disease risk factors and coronary artery calcium (CAC) scores were measured at baseline and year 10. Logistic regression models were used to estimate adjusted odds ratios (ORs) formyocardial scar. EXPOSURES Cardiovascular risk factors, CAC scores, left ventricle size and function, and carotid intima-media thickness. MAIN OUTCOMES AND MEASURES Myocardial scar detected by CMR imaging. RESULTS Of 1840 participants (mean [SD] age, 68 [9] years, 52%men), 146 (7.9%) had myocardial scars, of which 114 (78%) were undetected by electrocardiogram or by clinical adjudication. In adjusted models, age, male sex, body mass index, hypertension, and current smoking at baseline were associated with myocardial scar at year 10. The OR per 8.9-year increment was 1.61 (95%CI, 1.36-1.91; P <.001); for men vs women: OR, 5.76 (95%CI, 3.61-9.17; P <.001); per 4.8-SD body mass index: OR, 1.32 (95%CI, 1.09-1.61, P = .005); for hypertension: OR, 1.61 (95%CI, 1.12-2.30; P = .009); and for current vs never smokers: 2.00 (95%CI, 1.22-3.28; P = .006). Age-, sex-, and ethnicity-adjusted CAC scores at baseline were also associated withmyocardial scar at year 10. Compared with a CAC score of 0, the OR for scores from 1 through 99 was 2.4 (95%CI, 1.5-3.9); from 100 through 399, 3.0 (95%CI, 1.7-5.1), and 400 or higher, 3.3 (95%CI, 1.7-6.1) (P ≤ .001). The CAC score significantly added to the association ofmyocardial scar with age, sex, race/ethnicity, and traditional CVD risk factors (C statistic, 0.81 with CAC vs 0.79 without CAC, P = .01). CONCLUSIONS AND RELEVANCE The prevalence ofmyocardial scars in a US community-based multiethnic cohort was 7.9%, of which 78%were unrecognized by electrocardiography or clinical evaluation. Further studies are needed to understand the clinical consequences of these undetected scars.

Original languageEnglish (US)
Pages (from-to)1945-1954
Number of pages10
JournalJournal of the American Medical Association
Volume314
Issue number18
DOIs
StatePublished - Nov 10 2015

Fingerprint

Cicatrix
Coronary Vessels
Calcium
Odds Ratio
Cardiovascular Diseases
Electrocardiography
Body Mass Index
Logistic Models
Magnetic Resonance Imaging
Hypertension
Carotid Intima-Media Thickness
Gadolinium
Infarction
Population
Heart Ventricles
Atherosclerosis
Smoking

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Turkbey, E. B., Nacif, M. S., Guo, M., McClelland, R. L., Teixeira, P. B. R. P., Bild, D. E., ... Bluemke, D. A. (2015). Prevalence and correlates of myocardial scar in a US cohort. Journal of the American Medical Association, 314(18), 1945-1954. https://doi.org/10.1001/jama.2015.14849

Prevalence and correlates of myocardial scar in a US cohort. / Turkbey, Evrim B.; Nacif, Marcelo S.; Guo, Mengye; McClelland, Robyn L.; Teixeira, Patricia B R P; Bild, Diane E.; Barr, R. Graham; Shea, Steven; Post, Wendy S; Burke, Gregory; Budoff, Matthew J.; Folsom, Aaron R.; Liu, Chia Ying; Lima, Joao; Bluemke, David A.

In: Journal of the American Medical Association, Vol. 314, No. 18, 10.11.2015, p. 1945-1954.

Research output: Contribution to journalArticle

Turkbey, EB, Nacif, MS, Guo, M, McClelland, RL, Teixeira, PBRP, Bild, DE, Barr, RG, Shea, S, Post, WS, Burke, G, Budoff, MJ, Folsom, AR, Liu, CY, Lima, J & Bluemke, DA 2015, 'Prevalence and correlates of myocardial scar in a US cohort', Journal of the American Medical Association, vol. 314, no. 18, pp. 1945-1954. https://doi.org/10.1001/jama.2015.14849
Turkbey EB, Nacif MS, Guo M, McClelland RL, Teixeira PBRP, Bild DE et al. Prevalence and correlates of myocardial scar in a US cohort. Journal of the American Medical Association. 2015 Nov 10;314(18):1945-1954. https://doi.org/10.1001/jama.2015.14849
Turkbey, Evrim B. ; Nacif, Marcelo S. ; Guo, Mengye ; McClelland, Robyn L. ; Teixeira, Patricia B R P ; Bild, Diane E. ; Barr, R. Graham ; Shea, Steven ; Post, Wendy S ; Burke, Gregory ; Budoff, Matthew J. ; Folsom, Aaron R. ; Liu, Chia Ying ; Lima, Joao ; Bluemke, David A. / Prevalence and correlates of myocardial scar in a US cohort. In: Journal of the American Medical Association. 2015 ; Vol. 314, No. 18. pp. 1945-1954.
@article{aa1b310174c242df99c67744ca8a5416,
title = "Prevalence and correlates of myocardial scar in a US cohort",
abstract = "IMPORTANCE Myocardial scarring leads to cardiac dysfunction and poor prognosis. The prevalence of and factors associated with unrecognizedmyocardial infarction and scar have not been previously defined using contemporarymethods in a multiethnic US population. OBJECTIVE To determine prevalence of and factors associated withmyocardial scar in middle- and older-aged individuals in the United States. DESIGN, SETTING, AND PARTICIPANTS The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease (CVD) at baseline in 2000-2002. In the 10th year examination (2010-2012), 1840 participants underwent cardiac magnetic resonance (CMR) imaging with gadolinium to detectmyocardial scar. Cardiovascular disease risk factors and coronary artery calcium (CAC) scores were measured at baseline and year 10. Logistic regression models were used to estimate adjusted odds ratios (ORs) formyocardial scar. EXPOSURES Cardiovascular risk factors, CAC scores, left ventricle size and function, and carotid intima-media thickness. MAIN OUTCOMES AND MEASURES Myocardial scar detected by CMR imaging. RESULTS Of 1840 participants (mean [SD] age, 68 [9] years, 52{\%}men), 146 (7.9{\%}) had myocardial scars, of which 114 (78{\%}) were undetected by electrocardiogram or by clinical adjudication. In adjusted models, age, male sex, body mass index, hypertension, and current smoking at baseline were associated with myocardial scar at year 10. The OR per 8.9-year increment was 1.61 (95{\%}CI, 1.36-1.91; P <.001); for men vs women: OR, 5.76 (95{\%}CI, 3.61-9.17; P <.001); per 4.8-SD body mass index: OR, 1.32 (95{\%}CI, 1.09-1.61, P = .005); for hypertension: OR, 1.61 (95{\%}CI, 1.12-2.30; P = .009); and for current vs never smokers: 2.00 (95{\%}CI, 1.22-3.28; P = .006). Age-, sex-, and ethnicity-adjusted CAC scores at baseline were also associated withmyocardial scar at year 10. Compared with a CAC score of 0, the OR for scores from 1 through 99 was 2.4 (95{\%}CI, 1.5-3.9); from 100 through 399, 3.0 (95{\%}CI, 1.7-5.1), and 400 or higher, 3.3 (95{\%}CI, 1.7-6.1) (P ≤ .001). The CAC score significantly added to the association ofmyocardial scar with age, sex, race/ethnicity, and traditional CVD risk factors (C statistic, 0.81 with CAC vs 0.79 without CAC, P = .01). CONCLUSIONS AND RELEVANCE The prevalence ofmyocardial scars in a US community-based multiethnic cohort was 7.9{\%}, of which 78{\%}were unrecognized by electrocardiography or clinical evaluation. Further studies are needed to understand the clinical consequences of these undetected scars.",
author = "Turkbey, {Evrim B.} and Nacif, {Marcelo S.} and Mengye Guo and McClelland, {Robyn L.} and Teixeira, {Patricia B R P} and Bild, {Diane E.} and Barr, {R. Graham} and Steven Shea and Post, {Wendy S} and Gregory Burke and Budoff, {Matthew J.} and Folsom, {Aaron R.} and Liu, {Chia Ying} and Joao Lima and Bluemke, {David A.}",
year = "2015",
month = "11",
day = "10",
doi = "10.1001/jama.2015.14849",
language = "English (US)",
volume = "314",
pages = "1945--1954",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "18",

}

TY - JOUR

T1 - Prevalence and correlates of myocardial scar in a US cohort

AU - Turkbey, Evrim B.

AU - Nacif, Marcelo S.

AU - Guo, Mengye

AU - McClelland, Robyn L.

AU - Teixeira, Patricia B R P

AU - Bild, Diane E.

AU - Barr, R. Graham

AU - Shea, Steven

AU - Post, Wendy S

AU - Burke, Gregory

AU - Budoff, Matthew J.

AU - Folsom, Aaron R.

AU - Liu, Chia Ying

AU - Lima, Joao

AU - Bluemke, David A.

PY - 2015/11/10

Y1 - 2015/11/10

N2 - IMPORTANCE Myocardial scarring leads to cardiac dysfunction and poor prognosis. The prevalence of and factors associated with unrecognizedmyocardial infarction and scar have not been previously defined using contemporarymethods in a multiethnic US population. OBJECTIVE To determine prevalence of and factors associated withmyocardial scar in middle- and older-aged individuals in the United States. DESIGN, SETTING, AND PARTICIPANTS The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease (CVD) at baseline in 2000-2002. In the 10th year examination (2010-2012), 1840 participants underwent cardiac magnetic resonance (CMR) imaging with gadolinium to detectmyocardial scar. Cardiovascular disease risk factors and coronary artery calcium (CAC) scores were measured at baseline and year 10. Logistic regression models were used to estimate adjusted odds ratios (ORs) formyocardial scar. EXPOSURES Cardiovascular risk factors, CAC scores, left ventricle size and function, and carotid intima-media thickness. MAIN OUTCOMES AND MEASURES Myocardial scar detected by CMR imaging. RESULTS Of 1840 participants (mean [SD] age, 68 [9] years, 52%men), 146 (7.9%) had myocardial scars, of which 114 (78%) were undetected by electrocardiogram or by clinical adjudication. In adjusted models, age, male sex, body mass index, hypertension, and current smoking at baseline were associated with myocardial scar at year 10. The OR per 8.9-year increment was 1.61 (95%CI, 1.36-1.91; P <.001); for men vs women: OR, 5.76 (95%CI, 3.61-9.17; P <.001); per 4.8-SD body mass index: OR, 1.32 (95%CI, 1.09-1.61, P = .005); for hypertension: OR, 1.61 (95%CI, 1.12-2.30; P = .009); and for current vs never smokers: 2.00 (95%CI, 1.22-3.28; P = .006). Age-, sex-, and ethnicity-adjusted CAC scores at baseline were also associated withmyocardial scar at year 10. Compared with a CAC score of 0, the OR for scores from 1 through 99 was 2.4 (95%CI, 1.5-3.9); from 100 through 399, 3.0 (95%CI, 1.7-5.1), and 400 or higher, 3.3 (95%CI, 1.7-6.1) (P ≤ .001). The CAC score significantly added to the association ofmyocardial scar with age, sex, race/ethnicity, and traditional CVD risk factors (C statistic, 0.81 with CAC vs 0.79 without CAC, P = .01). CONCLUSIONS AND RELEVANCE The prevalence ofmyocardial scars in a US community-based multiethnic cohort was 7.9%, of which 78%were unrecognized by electrocardiography or clinical evaluation. Further studies are needed to understand the clinical consequences of these undetected scars.

AB - IMPORTANCE Myocardial scarring leads to cardiac dysfunction and poor prognosis. The prevalence of and factors associated with unrecognizedmyocardial infarction and scar have not been previously defined using contemporarymethods in a multiethnic US population. OBJECTIVE To determine prevalence of and factors associated withmyocardial scar in middle- and older-aged individuals in the United States. DESIGN, SETTING, AND PARTICIPANTS The Multi-Ethnic Study of Atherosclerosis (MESA) study is a population-based cohort in the United States. Participants were aged 45 through 84 years and free of clinical cardiovascular disease (CVD) at baseline in 2000-2002. In the 10th year examination (2010-2012), 1840 participants underwent cardiac magnetic resonance (CMR) imaging with gadolinium to detectmyocardial scar. Cardiovascular disease risk factors and coronary artery calcium (CAC) scores were measured at baseline and year 10. Logistic regression models were used to estimate adjusted odds ratios (ORs) formyocardial scar. EXPOSURES Cardiovascular risk factors, CAC scores, left ventricle size and function, and carotid intima-media thickness. MAIN OUTCOMES AND MEASURES Myocardial scar detected by CMR imaging. RESULTS Of 1840 participants (mean [SD] age, 68 [9] years, 52%men), 146 (7.9%) had myocardial scars, of which 114 (78%) were undetected by electrocardiogram or by clinical adjudication. In adjusted models, age, male sex, body mass index, hypertension, and current smoking at baseline were associated with myocardial scar at year 10. The OR per 8.9-year increment was 1.61 (95%CI, 1.36-1.91; P <.001); for men vs women: OR, 5.76 (95%CI, 3.61-9.17; P <.001); per 4.8-SD body mass index: OR, 1.32 (95%CI, 1.09-1.61, P = .005); for hypertension: OR, 1.61 (95%CI, 1.12-2.30; P = .009); and for current vs never smokers: 2.00 (95%CI, 1.22-3.28; P = .006). Age-, sex-, and ethnicity-adjusted CAC scores at baseline were also associated withmyocardial scar at year 10. Compared with a CAC score of 0, the OR for scores from 1 through 99 was 2.4 (95%CI, 1.5-3.9); from 100 through 399, 3.0 (95%CI, 1.7-5.1), and 400 or higher, 3.3 (95%CI, 1.7-6.1) (P ≤ .001). The CAC score significantly added to the association ofmyocardial scar with age, sex, race/ethnicity, and traditional CVD risk factors (C statistic, 0.81 with CAC vs 0.79 without CAC, P = .01). CONCLUSIONS AND RELEVANCE The prevalence ofmyocardial scars in a US community-based multiethnic cohort was 7.9%, of which 78%were unrecognized by electrocardiography or clinical evaluation. Further studies are needed to understand the clinical consequences of these undetected scars.

UR - http://www.scopus.com/inward/record.url?scp=84946763083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946763083&partnerID=8YFLogxK

U2 - 10.1001/jama.2015.14849

DO - 10.1001/jama.2015.14849

M3 - Article

C2 - 26547466

AN - SCOPUS:84946763083

VL - 314

SP - 1945

EP - 1954

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 18

ER -